Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

caruso's natural health pty ltd - pueraria lobata, quantity: 125 mg (equivalent: pueraria lobata, qty 1.25 g); actaea racemosa, quantity: 40 mg (equivalent: actaea racemosa, qty 200 mg); vitex agnus-castus, quantity: 20 mg (equivalent: vitex agnus-castus, qty 120 mg); tribulus terrestris, quantity: 25 mg (equivalent: tribulus terrestris, qty 1.25 g); eleutherococcus senticosus, quantity: 133.34 mg (equivalent: eleutherococcus senticosus, qty 2 g); colecalciferol, quantity: 0.0125 mg - tablet, film coated - excipient ingredients: liquid glucose; microcrystalline cellulose; povidone; crospovidone; croscarmellose sodium; calcium hydrogen phosphate dihydrate; silicon dioxide; magnesium stearate; hypromellose; macrogol 8000; titanium dioxide; indigo carmine aluminium lake; carnauba wax; maize starch; acacia; dl-alpha-tocopherol; sucrose; medium chain triglycerides; colour - aids/assists with recovery from illness/convalescence ; enhance/promote/physical endurance/capacity/stamina ; maintain/support physical endurance/capacity/stamina ; relieve weariness/tiredness/fatigue/feeling of weakness ; maintain/support bone health ; aids/assists healthy bone development/growth/building ; maintain/support bone mass/density/integrity ; maintain/support (state mineral) absorption in bones ; maintain/support bone strength ; help maintain/support bone mineralisation ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; traditionally used in chinese medicine to adaptogen/help body adapt to stress ; aids/assists the body to cope with environmental stress ; support healthy body stress recovery ; support healthy stress response in the body ; decrease/reduce/relieve symptoms of stress ; decrease/reduce mental/cognitive fatigue ; maintain/support mental concentration/focus/clarity ; decrease/reduce/relieve sleeplessness ; decrease/reduce/relieve disturbed/restless sleep ; traditionally used in ayurvedic medicine to uterine tonic/enhance uterine health ; maintain/support female reproductive system health ; traditionally used in chinese medicine to maintain/support female reproductive system health ; decrease/reduce/relieve menstrual spasms/cramps ; decrease/reduce/relieve symptoms of premenstrual tension ; helps reduce occurrence of premenstrual tension symptoms ; decrease/reduce/relieve symptoms of menstruation ; maintain/support healthy female hormonal balance during menopause ; helps decrease/reduce/relieve night sweats associated with menopause ; decrease/reduce/relieve symptoms of menopause ; helps reduce occurrence of menopausal symptoms ; decrease/reduce/relieve hot flushes associated with menopause ; decrease/reduce/relieve aggression/irritability associated with menopause ; traditionally used in ayurvedic medicine to aphrodisiac/enhance/improve/promote healthy libido ; aphrodisiac/enhance/improve/promote healthy libido ; maintain/support healthy libido ; traditionally used in ayurvedic medicine to maintain/support healthy sexual function ; maintain/support healthy sexual function

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - estradiol, quantity: 1 mg (equivalent: estradiol hemihydrate, qty 1.03 mg); dydrogesterone, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; hypromellose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uteri. prevention of postmenopausal bone mineral density loss in women. for initiation and continuation of treatment of postmenopausal symptoms, the lowest possible effective dose for the shortest duration should be used with the goal being short term use.

Singapur - İngilizce - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - estradiol valerate (in brown tablet); estradiol valerate (in white tablet); norgestrel (in brown tablet) - tablet, sugar coated - 2 mg - estradiol valerate (in brown tablet) 2 mg; estradiol valerate (in white tablet) 2 mg; norgestrel (in brown tablet) 0.5 mg

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

orpharma pty ltd - nitisinone, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; glycerol dibehenate - nityr tablets (nitisinone) are indicated for the treatment of patients with hereditary tyrosinaemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

orpharma pty ltd - nitisinone, quantity: 2 mg - tablet - excipient ingredients: lactose monohydrate; glycerol dibehenate - nityr tablets (nitisinone) are indicated for the treatment of patients with hereditary tyrosinaemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

orpharma pty ltd - nitisinone, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; glycerol dibehenate - nityr tablets (nitisinone) are indicated for the treatment of patients with hereditary tyrosinaemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ethinylestradiol, quantity: 0.02 mg; drospirenone, quantity: 3 mg - tablet - excipient ingredients: polacrilin potassium; magnesium stearate; lactose monohydrate - drospirenone/ethinyloestradiol-alphapharm 3/20 is indicated for use as: ? an oral contraceptive. ? treatment of moderate acne vulgaris in women who seek oral contraception ? treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of drospirenone 3 mg/ethinyloestradiol 20 ?g tablets for pmdd was not assessed beyond 3 cycles. drospirenone 3 mg/ethinyloestradiol 20 ?g tablets has not been evaluated for treatment of pms (premenstrual syndrome) (see clinical trials).

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

recordati rare diseases australia pty ltd - carglumic acid, quantity: 200 mg - tablet, dispersible - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; sodium lauryl sulfate; croscarmellose sodium; hypromellose; sodium stearylfumarate - carbaglu is indicated in treatment of,? hyperammonaemia due to n-acetylglutamate synthase primary deficiency,? hyperammonaemia due to organic acidaemias such as:,-hyperammonaemia due to isovaleric acidaemia -hyperammonaemia due to methylmalonic acidaemia -hyperammonaemia due to propionic acidaemia

Singapur - İngilizce - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - dydrogesterone, micronized (in grey tablet); estradiol hemihydrate 1.03 mg eqv estradiol (micronised) (in grey tablet); estradiol hemihydrate 1.03 mg eqv estradiol (micronised) (in white tablet) - tablet, film coated - 10 mg - dydrogesterone, micronized (in grey tablet) 10 mg; estradiol hemihydrate 1.03 mg eqv estradiol (micronised) (in grey tablet) 1 mg; estradiol hemihydrate 1.03 mg eqv estradiol (micronised) (in white tablet) 1 mg

Singapur - İngilizce - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - (blue tablet) estradiol hemihydrate 2.07mg equivalent to; (red tablet) estradiol hemihydrate 1.03mg equivalent to; (white tablet) estradiol as hemihydrate 2.07mg equivalent to; (white tablet) norethisterone acetate - tablet, film coated - 2 mg - (blue tablet) estradiol hemihydrate 2.07mg equivalent to 2 mg; (red tablet) estradiol hemihydrate 1.03mg equivalent to 1 mg; (white tablet) estradiol as hemihydrate 2.07mg equivalent to 2 mg; (white tablet) norethisterone acetate 1 mg